D. Sykes

发表

Assessment of bothersomeness and impact on quality of life of urinary incontinence in women in France, Germany, Spain and the UK

S. Hunskaar, S. Papanicolaou, G. Lose, 2005, BJU international.

A description of health care provision and access to treatment for women with urinary incontinence in Europe -- a five-country comparison.

B. Monz, E. Chartier-Kastler, G. Samsioe, 2005, Maturitas.

The prevalence of urinary incontinence in women in four European countries

S. Hunskaar, D. Sykes, G. Lose, 2004, BJU international.

Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO).

C. Cooper, D. Torgerson, E. Martı́n-Mola, 2006, QJM : monthly journal of the Association of Physicians.

Pharmaceutical treatment of symptomatic vertebral fractures in primary care

C. Cooper, D. Torgerson, S. Puffer, 2004, Annals of the rheumatic diseases.

Patient-reported impact of urinary incontinence--results from treatment seeking women in 14 European countries.

B. Monz, S. Hunskaar, G. Samsioe, 2005, Maturitas.

Multiscale alterations in bone matrix quality increased fragility in steroid induced osteoporosis

A. Boyde, R. Cox, C. Esapa, 2016, Bone.

Help-seeking behaviour and associated factors among women with urinary incontinence in France, Germany, Spain and the United Kingdom.

S. Hunskaar, D. Sykes, G. Lose, 2005, European urology.

The cost-effectiveness of IVF in the UK: a comparison of three gonadotrophin treatments.

S. Palmer, J. van Loon, D. Sykes, 2001, Human Reproduction.

Cost-analysis comparison of outpatient see-and-treat hysteroscopy service with other hysteroscopy service models.

E. Sarıdoğan, D. Sykes, D. Tilden, 2010, Journal of minimally invasive gynecology.

Characteristics of female outpatients with urinary incontinence participating in a 6-month observational study in 14 European countries.

B. Monz, S. Hunskaar, G. Samsioe, 2005, Maturitas.

Medical resource utilisation and cost of care for women seeking treatment for urinary incontinence in an outpatient setting. Examples from three countries participating in the PURE study.

B. Monz, C. Hampel, S. Papanicolaou, 2005, Maturitas.

The hospital cost of vertebral fractures in the EU: estimates using national datasets

D. Sykes, H. Finnern, 2003, Osteoporosis International.

Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study

O. Johnell, J. Kanis, B. Jönsson, 2004, Osteoporosis International.

Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women

O. Johnell, C. Cooper, D. Sykes, 2006, Osteoporosis International.

Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden

O. Johnell, J. Kanis, B. Jönsson, 2012, PharmacoEconomics.

Health care costs of women with symptomatic vertebral fractures.

C. Cooper, D. Torgerson, S. Puffer, 2004, Bone.

Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden: an economic evaluation based on the MORE study.

O. Johnell, J. Kanis, B. Jönsson, 2004, PharmacoEconomics.

Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden

O. Johnell, J. Kanis, A. Odén, 2012, PharmacoEconomics.